Death and cardiovascular outcomes in end-stage renal failure patients on different modalities of dialysis.
| Autor: | Khoo CY; Department of Cardiology, National Heart Centre Singapore, Singapore., Gao F, Choong HL, Tan WXA, Koniman R, Fam JM, Yeo KK |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Annals of the Academy of Medicine, Singapore [Ann Acad Med Singap] 2022 Mar; Vol. 51 (3), pp. 136-142. |
| DOI: | 10.47102/annals-acadmedsg.20219 |
| Abstrakt: | Introduction: Cardiovascular morbidity and mortality in end-stage renal failure (ESRF) patients are high. We examined the incidence and predictors of death and acute myocardial infarction (AMI) in ESRF patients on different modalities of dialysis. Method: Data were obtained from a population-based database (National Registry Disease Offices) in Singapore. The study cohort comprised all adult patients initiated on dialysis between 2007 and 2012 who were closely followed for the development of death and AMI until September 2014. Cox regression methods were used to identify predictors of death and AMI. Results: Of 5,309 patients, 4,449 were on haemodialysis and 860 on peritoneal dialysis (PD). Mean age of the cohort was 61 (±13) years (44% women), of Chinese (67%), Malay (25%) and Indian (7%) ethnicities. By September 2014, the incidence of all-cause death was 34%; close to a third of the patients died from a cardiovascular cause. Age >60 years and the presence of ischaemic heart disease, diabetes, stroke, peripheral vascular disease and PD were identified as independent predictors of all-cause death. PD patients had lower odds of survival compared to patients on haemodialysis (hazard ratio 1.51, 95% confidence interval 1.35-1.70, P <0.0001). Predictors of AMI in this cohort were older age (>60 years) and the presence of ischaemic heart disease, diabetes, stroke, peripheral vascular disease and current/ex-smokers. There were no significant differences in the incidence of AMI between patients on PD and haemodialysis. Conclusion: The short-term incidence of death and AMI remains high in Singapore. Future studies should investigate the benefits of a tighter control of cardiovascular risk factors among ESRF patients on dialysis. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|